 |
NEWS
25-Feb-2007 - New NA Director of Business Development
FMS has recently contracted with Joe Farnsworth, RVT, as our Director of Business Development, North America. Joe is based in Maine and you can find his contact details in the distributor section. Welcome Joe!
05-Feb-2007 - Finometer Model-2 released by FDA
FMS has received the formal FDA-release for sale for the Finometer MIDI
(Finometer Model-2) in the USA.
30-Oct-2006 - FMS ships system #1000
The 1000th FMS system finds its new home in the Department of Neurology in the SMBD Jewish General Hospital in Montreal, Canada.
See Newsletter November 2006 for more information.
19-Oct-2006 - Finometer Model-2 released by TGA
FMS has received the formal TGA-release for sale for the Finometer MIDI
(Finometer Model-2) in Australia.
08-Aug-2006 - Finometer Model-2 released by CSA
The Finometer Midi license for Canada was received from Canada Health.
13-Jul-2006 - Finometer Model-2 gets CE Marking
Finapres Medical Systems received CE Marking of Conformity for the Finometer Midi (Finometer Model-2), two months after it was launched in the market.
15-May-2006 - Introducing Finometer Pro & Midi
The Finometer Pro is the successor of the current Finometer with new user friendly software (BeatScope Easy), ECG Module (option) and a fresh up-to-date look. The Finometer Midi is a new development based on the Finometer Pro, but without RTF calibration with an arm cuff and built-in flat screen.
See Newsletter for more information.
26-Oct-2005 - Products approved by KFDA, South Korea
On 21st October 2005, the Korean Food and Drug Administration has granted Finapres Medical Systems regulatory approvals on Finometer and Portapres. With those approvals, Finapres and Portapres can be sold in South Korea as medical devices for both clinical and research purposes.
20-Jul-2005 - Himalaya Research with Portapres
A group of British researchers and scientists at the Birmingham Medical Research Expeditionary Society has most recently completed an high altitude research project with the support from Finapres Medical Systems.
The unique ambulatory characteristic of Portapres allow the researchers to non-invasively record beat to beat haemodynamic changes during exercise on top of the Himalaya. The results of this study are expected to be published in international journals soon.
|
 |
 |
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
Himalaya Research with Portapres
|
|
|
